It is a pharma private limited company based in New Delhi, Delhi, India, established in 2010.
2010 | New Delhi, Delhi, India | ActiveEdura Pharmaceuticals Private Limited, a active private limited company, was established on 09 August 2010 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U52311DL2010PTC206871. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Vikas Gambhir (Director), Vikas (Director), Rajan Vohra (Director). Past directors included Ruby Shukla, Vikas Gambhir, Rohan Vasudeva. It holds ₹4.05 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-8/144, Pkt-8 Sector-8, Rohini, New Delhi, Delhi, 110085.
U52311DL2010PTC206871
206871
09 August 2010
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Edura Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Gambhir | Director | 13 Feb 2017 | Current |
| Vikas | Director | 15 Nov 2010 | Current |
| Rajan Vohra | Director | 09 Aug 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Mar 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 18 Nov 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Edura Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 42.11% increase. The company also saw a substantial improvement in profitability, with a 36.58% increase in profit. The company's net worth Soared by an impressive increase of 47.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Edura Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,050,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2023 | Axis Bank Limited | ₹2.00 M | Open |
| 27 Jan 2022 | Axis Bank Limited | ₹2.05 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Edura Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Edura Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edura Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Edura Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Edura Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Axis Bank Limited amounted to Rs. 2.00 M with Charge ID 100721327 was registered on 25 Feb 2023. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 2.05 M with Charge ID 100563515 was registered on 27 Jan 2022. was completed.
The activity Vikas Gambhir was appointed as a Director was appointed as a Director on 13 Feb 2017 & has been associated with this company since 8 years 10 months . was completed.
Progress on Vikas was appointed as a Director was appointed as a Director on 15 Nov 2010 & has been associated with this company since 15 years 1 month . was documented.
The CIN of Edura Pharmaceuticals Private Limited is U52311DL2010PTC206871.
Edura Pharmaceuticals Private Limited is headquartered at C-8/144, Pkt-8 Sector-8, Rohini, New Delhi, Delhi, 110085.
Edura Pharmaceuticals Private Limited was incorporated on 09 August 2010.
The current directors of Edura Pharmaceuticals Private Limited are
The primary industry of Edura Pharmaceuticals Private Limited is Trade.
Edura Pharmaceuticals Private Limited is unlisted.
The authorized capital of Edura Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Edura Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX